08:51 AM EDT, 04/09/2024 (MT Newswires) -- Health care stocks were mixed pre-bell Tuesday, with the Health Care Select Sector SPDR Fund (XLV) was recently inactive and the iShares Biotechnology ETF (IBB) up 0.3%.

Neogen (NEOG) was down more than 13% after saying it now expects fiscal 2024 revenue of $910 million to $920 million, lowering its previous outlook of $935 million to $955 million. Two analysts polled by Capital IQ are expecting $938.2 million.